Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Letter
  • Published:

Conversion of staphylococcal pathogenicity islands to CRISPR-carrying antibacterial agents that cure infections in mice

Nature Biotechnology volume 36, pages 971–976 (2018)Cite this article

Subjects

Abstract

Staphylococcus aureus and other staphylococci continue to cause life-threatening infections in both hospital and community settings1,2,3. They have become increasingly resistant to antibiotics, especially β-lactams and aminoglycosides, and their infections are now, in many cases, untreatable. Here we present a non-antibiotic, non-phage method of treating staphylococcal infections by engineering of the highly mobile staphylococcal pathogenicity islands (SaPIs). We replaced the SaPIs' toxin genes with antibacterial cargos to generate antibacterial drones (ABDs) that target the infecting bacteria in the animal host, express their cargo, kill or disarm the bacteria and thus abrogate the infection. Here we have constructed ABDs with either a CRISPR–Cas9 bactericidal or a CRISPR–dCas9 virulence-blocking module. We show that both ABDs block the development of a murine subcutaneous S. aureus abscess and that the bactericidal module rescues mice given a lethal dose of S. aureus intraperitoneally.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on SpringerLink
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1: SaPI and ABD structures.
Figure 2: ABD activities in vitro.
Figure 3: ABD blockade or cure of murine infections.

Similar content being viewed by others

References

  1. Kennedy, A.D. et al. Epidemic community-associated methicillin-resistant Staphylococcus aureus: recent clonal expansion and diversification. Proc. Natl. Acad. Sci. USA 105, 1327–1332 (2008).

    Article  CAS  Google Scholar 

  2. King, M.D. et al. Emergence of community-acquired methicillin-resistant Staphylococcus aureus USA 300 clone as the predominant cause of skin and soft-tissue infections. Ann. Intern. Med. 144, 309–317 (2006).

    Article  Google Scholar 

  3. Gould, I.M. et al. New insights into meticillin-resistant Staphylococcus aureus (MRSA) pathogenesis, treatment and resistance. Int. J. Antimicrob. Agents 39, 96–104 (2012).

    Article  CAS  Google Scholar 

  4. Lindsay, J.A., Ruzin, A., Ross, H.F., Kurepina, N. & Novick, R.P. The gene for toxic shock toxin is carried by a family of mobile pathogenicity islands in Staphylococcus aureus. Mol. Microbiol. 29, 527–543 (1998).

    Article  CAS  Google Scholar 

  5. Tallent, S.M., Langston, T.B., Moran, R.G. & Christie, G.E. Transducing particles of Staphylococcus aureus pathogenicity island SaPI1 are comprised of helper phage-encoded proteins. J. Bacteriol. 189, 7520–7524 (2007).

    Article  CAS  Google Scholar 

  6. Tormo-Más, M.A. et al. Moonlighting bacteriophage proteins derepress staphylococcal pathogenicity islands. Nature 465, 779–782 (2010).

    Article  Google Scholar 

  7. Ruzin, A., Lindsay, J. & Novick, R.P. Molecular genetics of SaPI1—a mobile pathogenicity island in Staphylococcus aureus. Mol. Microbiol. 41, 365–377 (2001).

    Article  CAS  Google Scholar 

  8. Wang, H., La Russa, M. & Qi, L.S. CRISPR/Cas9 in genome editing and beyond. Annu. Rev. Biochem. 85, 227–264 (2016).

    Article  CAS  Google Scholar 

  9. Novick, R.P. & Geisinger, E. Quorum sensing in staphylococci. Annu. Rev. Genet. 42, 541–564 (2008).

    Article  CAS  Google Scholar 

  10. Ji, G., Beavis, R.C. & Novick, R.P. Cell density control of staphylococcal virulence mediated by an octapeptide pheromone. Proc. Natl. Acad. Sci. USA 92, 12055–12059 (1995).

    Article  CAS  Google Scholar 

  11. Chen, J. & Novick, R.P. Phage-mediated intergeneric transfer of toxin genes. Science 323, 139–141 (2009).

    Article  CAS  Google Scholar 

  12. Chen, J., Ram, G., Penadés, J.R., Brown, S. & Novick, R.P. Pathogenicity island-directed transfer of unlinked chromosomal virulence genes. Mol. Cell 57, 138–149 (2015).

    Article  CAS  Google Scholar 

  13. Wright, J.S. III, Lyon, G.J., George, E.A., Muir, T.W. & Novick, R.P. Hydrophobic interactions drive ligand-receptor recognition for activation and inhibition of staphylococcal quorum sensing. Proc. Natl. Acad. Sci. USA 101, 16168–16173 (2004).

    Article  CAS  Google Scholar 

  14. Bunce, C., Wheeler, L., Reed, G., Musser, J. & Barg, N. Murine model of cutaneous infection with gram-positive cocci. Infect. Immun. 60, 2636–2640 (1992).

    CAS  PubMed  PubMed Central  Google Scholar 

  15. Brouillette, E. et al. DNA immunization against the clumping factor A (ClfA) of Staphylococcus aureus. Vaccine 20, 2348–2357 (2002).

    Article  CAS  Google Scholar 

  16. Ryan, E.M., Gorman, S.P., Donnelly, R.F. & Gilmore, B.F. Recent advances in bacteriophage therapy: how delivery routes, formulation, concentration and timing influence the success of phage therapy. J. Pharm. Pharmacol. 63, 1253–1264 (2011).

    Article  CAS  Google Scholar 

  17. Winstel, V. et al. Wall teichoic acid structure governs horizontal gene transfer between major bacterial pathogens. Nat. Commun. 4, 2345–2354 (2013).

    Article  Google Scholar 

  18. O'Flaherty, S. et al. Genome of staphylococcal phage K: a new lineage of Myoviridae infecting gram-positive bacteria with a low G+C content. J. Bacteriol. 186, 2862–2871 (2004).

    Article  CAS  Google Scholar 

  19. Labrie, S.J., Samson, J.E. & Moineau, S. Bacteriophage resistance mechanisms. Nat. Rev. Microbiol. 8, 317–327 (2010).

    Article  CAS  Google Scholar 

  20. Mayville, P. et al. Structure-activity analysis of synthetic autoinducing thiolactone peptides from Staphylococcus aureus responsible for virulence. Proc. Natl. Acad. Sci. USA 96, 1218–1223 (1999).

    Article  CAS  Google Scholar 

  21. Weil, J., Cunningham, R., Martin, R. III, Mitchell, E. & Bolling, B. Characteristics of lambda p4, a lambda derivative containing 9 per cent excess DNA. Virology 50, 373–380 (1972).

    Article  CAS  Google Scholar 

  22. Frischauf, A.M., Lehrach, H., Poustka, A. & Murray, N. Lambda replacement vectors carrying polylinker sequences. J. Mol. Biol. 170, 827–842 (1983).

    Article  CAS  Google Scholar 

  23. Citorik, R.J., Mimee, M. & Lu, T.K. Sequence-specific antimicrobials using efficiently delivered RNA-guided nucleases. Nat. Biotechnol. 32, 1141–1145 (2014).

    Article  CAS  Google Scholar 

  24. Bikard, D. et al. Exploiting CRISPR-Cas nucleases to produce sequence-specific antimicrobials. Nat. Biotechnol. 32, 1146–1150 (2014).

    Article  CAS  Google Scholar 

  25. Novick, R.P. Genetic systems in staphylococci. Methods Enzymol. 204, 587–636 (1991).

    Article  CAS  Google Scholar 

  26. Stocker, B.A. Abortive transduction of motility in Salmonella; a nonreplicated gene transmitted through many generations to a single descendant. J. Gen. Microbiol. 15, 575–598 (1956).

    Article  CAS  Google Scholar 

  27. Ozeki, H. Chromosome fragments participating in transduction in Salmonella Typhimurium. Genetics 44, 457–470 (1959).

    CAS  PubMed  PubMed Central  Google Scholar 

  28. Arber, W. Transduction of chromosomal genes and episomes in Escherichia coli. Virology 11, 273–288 (1960).

    Article  CAS  Google Scholar 

Download references

Acknowledgements

This work was supported by NIH grant R01-AI22159 to RPN and by a grant-in-aid from NYU School of Medicine. The animal experiments described in this paper were conducted in conformity with all relevant ethical regulations, under IACUC protocol 160722-01, approved by the NYUSOM IACUC on 7/21/16.

Author information

Author notes

  1. Geeta Ram

    Present address: Present address: Regional Centre for Biotechnology, NCR Biotech Science Cluster, Faridabad, India.,

  2. Geeta Ram, Hope F Ross and Richard P Novick: These authors contributed equally to this work.

Authors and Affiliations

  1. Departments of Microbiology and Medicine, New York University School of Medicine, New York, New York, USA

    Geeta Ram, Hope F Ross, Richard P Novick, Ivelisse Rodriguez-Pagan & Dunrong Jiang

Authors
  1. Geeta Ram
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Hope F Ross
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Richard P Novick
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Ivelisse Rodriguez-Pagan
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Dunrong Jiang
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

R.P.N., H.F.R. and G.R. planned and discussed the experiments. H.F.R. had the initial idea; G.R. and H.F.R. did the cloning; G.R. performed the in vitro tests; I.R.-P. and R.P.N. did the mouse experiments; D.J. did the DNA preparations; and R.P.N. did the microbiological work and wrote the manuscript.

Corresponding authors

Correspondence to Geeta Ram, Hope F Ross or Richard P Novick.

Ethics declarations

Competing interests

A patent application has been filed by New York University, with G.R., H.F.R. and R.P.N. as inventors, on the basis of results presented in this paper.

Supplementary information

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Ram, G., Ross, H., Novick, R. et al. Conversion of staphylococcal pathogenicity islands to CRISPR-carrying antibacterial agents that cure infections in mice. Nat Biotechnol 36, 971–976 (2018). https://doi.org/10.1038/nbt.4203

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nbt.4203

Search

Advanced search

Quick links

Nature Briefing: Translational Research

Sign up for the Nature Briefing: Translational Research newsletter — top stories in biotechnology, drug discovery and pharma.

Get what matters in translational research, free to your inbox weekly. Sign up for Nature Briefing: Translational Research